Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSANGAMO THERAPEUTICS, INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SANGAMO THERAPEUTICS, INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
May 25, 2026Macrae SandyPRESIDENT, CEO AND DIRECTOR12,613Common Stock—Tax withholding
May 25, 2026Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY4,036Common Stock—Tax withholding
May 25, 2026Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER4,036Common Stock—Tax withholding
May 25, 2026Davis Gregory DHead of Research & Technology1,630Common Stock—Tax withholding
May 25, 2026Jain NikunjPrincipal Accounting Officer1,919Common Stock—Tax withholding
Apr 22, 2026Davis Gregory DHead of Research & Technology69,827Common Stock—Sell
Apr 21, 2026Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER345,942Common Stock—Sell
Apr 1, 2026Macrae SandyPRESIDENT, CEO AND DIRECTOR2,500,000Stock Option (Right to Buy)—Grant / award
Apr 1, 2026Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY800,000Stock Option (Right to Buy)—Grant / award
Apr 1, 2026Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER800,000Stock Option (Right to Buy)—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions